Mark T. Leibowitz
Impact in
- Psychiatry and Mental health top 10%
- Migraine and Headache Studies
- Dementia and Cognitive Impairment Research
- Pharmacology top 5%
- Cholinesterase and Neurodegenerative Diseases
- Pharmacology and Obesity Treatment
Papers in
-
- SARS-CoV-2 and COVID-19 Research 5
-
- Migraine and Headache Studies 2
- Co-authors
- Larry Ereshefsky (5 shared papers)S. S. Jhee (4 shared papers)Silke Appel‐Dingemanse (1 shared paper)Heinz Schmidli (1 shared paper)Francoise Pommier (1 shared paper)Gilbert Y. Lefèvre (1 shared paper)Albert Enz (1 shared paper)Greg Sedek (1 shared paper)
- Journals
- JAMA Network Open (4 papers)Clinical Therapeutics (2 papers)The Journal of Clinical Pharmacology (2 papers)Journal of Cardiovascular Pharmacology (2 papers)Journal of Clinical Psychopharmacology (2 papers)
- Partner nations
- United StatesSwitzerlandBelgium
In The Last Decade
Mark T. Leibowitz
23 papers receiving 866 citations
Mark T. Leibowitz's Hit Papers
Peers
Comparison fields: 5 of 67
- Psychiatry and Mental health 191
- Pharmacology 145
- Neurology 86
- Cardiology and Cardiovascular Medicine 125
- Pharmaceutical Science 31
Countries citing papers authored by Mark T. Leibowitz
This map shows the geographic impact of Mark T. Leibowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark T. Leibowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark T. Leibowitz more than expected).
Fields of papers citing papers by Mark T. Leibowitz
This network shows the impact of papers produced by Mark T. Leibowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark T. Leibowitz. The network helps show where Mark T. Leibowitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark T. Leibowitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 116 | |
| 2 | 2021 | 104 | |
| 3 | 2001 | 97 | |
| 4 | RNA Interference With Zilebesiran for Mild to Moderate Hypertension Hit paper breakdown → | 2024 | 86 |
| 5 | 2002 | 64 | |
| 6 | 2009 | 58 | |
| 7 | 2007 | 55 | |
| 8 | 2002 | 52 | |
| 9 | 2008 | 50 | |
| 10 | 2023 | 42 | |
| 11 | 2001 | 36 | |
| 12 | 2014 | 32 | |
| 13 | 2007 | 31 | |
| 14 | 2006 | 30 | |
| 15 | 2004 | 18 | |
| 16 | 2023 | 14 | |
| 17 | 2012 | 8 | |
| 18 | 2023 | 8 | |
| 19 | 2012 | 7 | |
| 20 | 2016 | 7 |
About Mark T. Leibowitz
Mark T. Leibowitz is a scholar working on Infectious Diseases, Psychiatry and Mental health, Pharmacology, Anesthesiology and Pain Medicine and Pharmacology, having authored 23 papers that have together received 923 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (5 papers), Sleep and related disorders (2 papers), Migraine and Headache Studies (2 papers), Blood Pressure and Hypertension Studies (2 papers), Pain Management and Opioid Use (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Parkinson's Disease Mechanisms and Treatments (2 papers) and Cholinesterase and Neurodegenerative Diseases (1 paper). The work is most often cited by research in Psychiatry and Mental health (191 citations), Pharmacology (145 citations), Neurology (86 citations), Cardiology and Cardiovascular Medicine (125 citations) and Pharmaceutical Science (31 citations). Mark T. Leibowitz has collaborated with scholars based in United States, Switzerland and Belgium. Frequent co-authors include Larry Ereshefsky, S. S. Jhee, Silke Appel‐Dingemanse, Heinz Schmidli, Francoise Pommier, Gilbert Y. Lefèvre, Albert Enz, Greg Sedek, Timothy Ryan Smith and Baltazar Gomez‐Mancilla. Their work appears in journals such as JAMA Network Open, Clinical Therapeutics, The Journal of Clinical Pharmacology, Journal of Cardiovascular Pharmacology and Journal of Clinical Psychopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.